Prentiss Smith & Co’s Amgen AMGN Stock Holding History

Prentiss Smith & Co’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-150	Closed	-$31K	–	73
2018 Q3	$31K	Hold	150	–	–	0.02%	140
2018 Q2	$28K	Hold	150	–	–	0.02%	154
2018 Q1	$26K	Hold	150	–	–	0.01%	164
2017 Q4	$26K	Hold	150	–	–	0.01%	167
2017 Q3	$28K	Hold	150	–	–	0.02%	146
2017 Q2	$26K	Hold	150	–	–	0.01%	149
2017 Q1	$25K	Hold	150	–	–	0.01%	149
2016 Q4	$22K	Hold	150	–	–	0.01%	159
2016 Q3	$25K	Hold	150	–	–	0.01%	160
2016 Q2	$23K	Hold	150	–	–	0.01%	157
2016 Q1	$22K	Hold	150	–	–	0.01%	178
2015 Q4	$24K	Sell	150 -305	-67%	-$47.9K	0.01%	179
2015 Q3	$63K	Hold	455	–	–	0.03%	107
2015 Q2	$70K	Hold	455	–	–	0.03%	109
2015 Q1	$73K	Hold	455	–	–	0.03%	111
2014 Q4	$72K	Buy	455 +63	+16%	+$9.82K	0.03%	115
2014 Q3	$55K	Buy	392 +1	+0.3%	+$131	0.03%	105
2014 Q2	$46K	Buy	391 +2	+0.5%	+$232	0.02%	115
2014 Q1	$48K	Buy	389 +1	+0.3%	+$121	0.03%	120
2013 Q4	$44K	Buy	388 +2	+0.5%	+$228	0.02%	120
2013 Q3	$43K	Buy	386 +45	+13%	+$4.88K	0.02%	122
2013 Q2	$34K	Buy	+341	New	+$35.4K	0.02%	138

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Prentiss Smith & Co's AMGN Position: Q4 2018 in Review

Prentiss Smith & Co sold out of Amgen (AMGN) in Q4 2018, closing a stake of 150 shares — an estimated $31K sold.

Prentiss Smith & Co first reported a position in AMGN in Q2 2013 and held it in 22 quarters. The position peaked at $73K in Q1 2015. 1,892 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

Prentiss Smith & Co reported no remaining Amgen position as of Q4 2018 after selling out during the quarter.
Prentiss Smith & Co sold 150 Amgen shares in Q4 2018, an estimated $31K.
Prentiss Smith & Co first reported a position in Amgen in Q2 2013 and held it in 22 quarters.
Prentiss Smith & Co's Amgen position peaked at $73K in Q1 2015.
1,892 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on Prentiss Smith & Co's 13F filing for Q4 2018, filed 15 Jan 2019.